Blakely T, Tobias M et al. Tracking disparity: Trends in ethnic and socioeconomic inequalities in mortality, Wellington: Ministry of
|
|
- Melissa Riley
- 5 years ago
- Views:
Transcription
1 Ethnic disparities in colon cancer survival in New Zealand Dr Diana Sarfati University of Otago Wellington Māori Cancer Conference; Aug 2009
2 Acknowledgements Sarah Hill Project team Bridget Robson, Donna Cormack, Tony Blakely, Gordon Purdie, Liz Dennett, Kevin Dew Cancer Society of New Zealand
3 Colorectal cancer mortality rates by ethnicity Blakely T, Tobias M et al. Tracking disparity: Trends in ethnic and socioeconomic inequalities in mortality, Wellington: Ministry of Health
4 Colorectal cancer incidence by ethnicity for men aged 25 yrs + Shaw, Blakely, Atkinson, Tobias, Sarfati, Cunningham. CancerTrends: Preliminary results. [Not for distribution]
5 Maori : non-maori/ non-pacific RSRR 1 Maori: non-maori/non-p Pacific RSRRs Bladder Breast Cervix Colon/rectum Lung Prostate Jeffreys M, Stevanovic V, et al. Ethnic differences in cancer survival in New Zealand: linkage study. Am J Public Health 2005;95:834-7.
6 Proportion attributable to stage Maori:non-Maori/non-Pa acific R SRRs Bladder Breast Cervix Colon/rectum Lung Prostate Age-standardised Additional stage standardisation Remaining portion Jeffreys M, Stevanovic V, et al. Ethnic differences in cancer survival in New Zealand: linkage study. Am J Public Health 2005;95:834-7.
7 Study Questions: Verify Māori / non-māori survival disparity (for colon ca) What factors contribute to this survival disparity? Tumour characteristics Patient comorbidity Health services
8 Retrospective cohort: 301 Māori, 328 non-māori patients diagnosed NZ Health Information Service Cancer Registry Study Cohort Ethnicity Hospitalisation Database Medical Charts Demographics Tumour Comorbidity Health care Mortality Database Survival
9 Cancer-specific survival Surviva al
10 Reasons for poorer survival in Māori???? More aggressive / advanced tumours Greater comorbidity Poorer health care Differences in treatment Differences in markers of health care access / quality
11 Tumour characteristics: grade of tumour Well differentiated Moderately differentiated Poorly differentiated Percentageo of cohort Mäori non-mäori
12 Tumour characteristics: stage at diagnosis* Percentage of cohort Stage I Stage II Stage III Stage IV Unstaged Māori non-māori *Age- and sex-standardised prevalence
13 χ Reasons for poorer survival in Māori?? More aggressive / advanced tumours Greater comorbidity? Poorer health care Differences in treatment Differences in markers of health care access / quality
14 Patient comorbidity* 60 p= Māori non-māori 50 Percentage e of cohort P< P< P=0.02 P= Hypertension Previous heart attack Heart failure Diabetes Respiratory disease Previous stroke or TIA Renal disease Neurological disease *Age- and sex-standardised prevalence
15 Effect of comorbidity on survival Adjusted hazard ratios for cancer specific and all-cause survival among 589 colon cancer patients by specified comorbidity Cancer specific all-cause Hazard Ratio Angina Hypertension Previous MI Arrhythmias CHF PVD Resp. disease GI ulcer Other cancer Cerebrovasc disease Diabetes Renal disease Other neuro 0 1 0r 2 3 or more or more Charlson Index Comorbidity count Adjusted for age, sex, ethnicity, smoking, year of diagnosis, stage, grade, site of cancer
16 Effect on treatment choice Of 190 patients in our cohort with Stage III disease, 68% were offered chemotherapy. Older patients and those with higher comorbidity were considerably less likely to be offered chemotherapy. 84% with Charlson comorbidity score=0 cf 19% with Charlson comorbidity score of 3+ were offered chemotherapy 80% of yr cf 37% of 75yr + were offered chemotherapy Among those with highest comorbidity there was around a 60% reduction in excess risk of death if offered chemotherapy.
17 Reasons for poorer survival in Māori?? χ More aggressive / advanced tumours Greater comorbidity Poorer health care Differences in treatment Differences in markers of health care access / quality
18 Treatment Surgery* Māori non-māori Percentage e of cohort Removal primary tumour Palliative operation Elective surgery *Age- and sex-standardised prevalence Emergency surgery Obstructed Perforated Obstructed or perforated
19 Treatment: number of lymph nodes removed during surgery percentage of co ohort Māori non-māori Number of lymph nodes
20 Post-operative mortality 20 Māori non-māori Adjusted for patient and clinical factors: Percentage of cohort All surgery: RR = 3.17 ( ) Elective surgery: RR = 5.15 ( ) 0 Death following any surgery Death following elective surgery
21 Chemotherapy (stage III)* Treatment Referred to oncologist Reviewed by oncologist Offered adjuvant chemo Percentage of coh hort (stage III) Received adjuvant chemo Started within 8 weeks 10 0 Māori *Age- and sex-standardised prevalence non-māori
22 Markers of health care access / quality Proportion of (Māori/n non-māori) cohort Treatment facility type Area deprivation Māori non-māori Rurality 0 2 public 3 public private 0 1 (high SES) (low SES) 0 Urban Semiurban Rural
23 Reasons for poorer survival in Māori? χ More aggressive / advanced tumours Greater comorbidity Poorer health care Differences in treatment Differences in markers of health care access / quality
24 Māori/non-Māori hazard ratio (RR): step-wise adjustment for explanatory variables Adjusted for: HR (95% CI) Unadjusted 1.33 ( ) i) Demographics 1.30 ( ) ii) + Tumour characteristics 1.33 ( ) iii) + Patient comorbidity/smoking 1.20* ( ) iv) + Treatment 1.17 ( ) v) + Health care access / quality 1.07* ( ) *Signficant change from previous HR (Hausman test) Hausman J. Specification tests in econometrics. Econometrica 1978;46(6):1251-7
25 Conclusions Māori patients have significantly poorer survival from colon cancer compared with non-māori patients (HR 1.33) Greater comorbidity levels and differences in health care access are both important mediators of worse survival in Māori (each accounts for ~1/3 of the total disparity)
26 What does this mean? Māori patients have poorer access to quality health care compared with non-māori Māori patients have lower cancer survival compared with non-māori
27 Where to from here? System factors Resourcing and location of cancer services Focus of cancer services (structure, organisation delivery of services reflect Pakeha world view) Composition of cancer service workforce Regional factors Improve access to specialists in rural areas Increase support for patients and whãnau travelling to cancer services Specialist support for local clinicians Coordination of case management through cancer care pathway Clinical factors Optimise treatment of those with comorbidity Evaluation of patient management against clinical guidelines/ audit in peer review context Training in cultural safety
28
C3: Cancer, Care and Comorbidity
C3: Cancer, Care and Comorbidity Symposium April 2014 Comorbidity: Why do we care? is common among cancer patients. has a major impact on patients. has a major impact on health services. Is an important
More informationTrends and disparities in cancer in Aotearoa/ NZ
Trends and disparities in cancer in Aotearoa/ NZ Professor Diana Sarfati #cancercrossroads @DiSarfati Why cancer? Estimated number of incident cases from 2018 to 2040 in New Zealand, all cancers, both
More informationCancer, Care and Comorbidity. Associate Professor Diana Sarfati
Cancer, Care and Comorbidity Associate Professor Diana Sarfati Why do we care? Comorbidity: is common among cancer patients. has a major impact on patients. has a major impact on health services. Is an
More informationColorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati
Colorectal cancer New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati Today s talk Mortality Internationally In New Zealand Incidence Trends in New Zealand Primary prevention
More informationEthnic inequalities in mortality: Trends and explanations,
Pharmac, Oct 2009 Professor Tony Blakely Ethnic inequalities in mortality: Trends and explanations, 1981-2004 Acknowledgments: Tobias, Atkinson, Woodward, and too many more to name 1 Index Structure of
More informationThe uneven playing field: Inequi3es in cancer care and outcomes in New Zealand
The uneven playing field: Inequi3es in cancer care and outcomes in New Zealand Māori: Indigenous New Zealanders British colonisation Māori now 15% NZ pop Health inequalities All cancers, incidence and
More informationWhat were the key findings from the routinely-collected data?
What were the key findings from the routinely-collected data? Dr Jason Gurney MoH National Health Board Cancer Registry (n=14,096) Hospitalisation and other Databases Mortality Database Notes Review (Upper
More informationCaring for cancer patients with comorbidity. Chair: Associate Professor Diana Sarfa3
Caring for cancer patients with comorbidity Chair: Associate Professor Diana Sarfa3 Why do we care? Comorbidity: is common among cancer pa3ents. has a major impact on pa3ents. has a major impact on health
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association What proportion of cancer is due to obesity? Tony Blakely, Diana Sarfati, Caroline Shaw The evidence linking overweight and
More informationAppendix Two. Epidemiology of HER2-positive breast cancer in New Zealand including regional and ethnic disparties
Appendix Two. Epidemiology of HER2-positive breast cancer in New Zealand including regional and ethnic disparties Health need is one of PHARMAC s nine decision criteria (http://www.pharmac.govt.nz/pdf/231205.pdf
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association How well does routine hospitalisation data capture information on comorbidity in New Zealand? Diana Sarfati, Sarah Hill, Gordon
More informationNumbers and Narratives
Unequal Impact: Numbers and Narratives Revolution of Cancer Care, National Māori Cancer Forum Rotorua, August 2009 Bridget Robson and Donna Cormack Te Rōpū RangahauHauoraa EruPōmare University of Otago
More informationUnequal Impact: Māori and Non-Māori Cancer Statistics
Unequal Impact: Māori and Non-Māori Cancer Statistics 1996 2001 Te Rōpū Rangahau Hauora a Eru Pōmare Wellington School of Medical and Health Sciences Wellington Suggested citation: Robson B, Purdie G,
More informationCancer in Pacific people in New Zealand: a descriptive study
Cancer in Pacific people in New Zealand: a descriptive study Abstract: Non-Mâori Pacific people constitute a significant and rapidly growing population in New Zealand. An accompanying change in lifestyle
More informationProfessor Norman Sharpe. Heart Foundation West Coast
Professor Norman Sharpe Heart Foundation West Coast Primary Care the Keystone to Heart Health Improvement Norman Sharpe June 2013 The heart health continuum and the keystone position The culprit disease
More informationReport to Waikato Medical Research Foundation
Report to Waikato Medical Research Foundation Understanding the importance of tumour biology and socio-demographic difference in cancer stage at diagnosis using the Midland Lung Cancer Register Ross Lawrenson
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Bias in relative survival methods when using incorrect life-tables: Lung and bladder cancer by smoking status and ethnicity in New Zealand Tony Blakely 1, Matthew Soeberg
More informationDownloaded from:
Jeffreys, M; Stevanovic, V; Tobias, M; Lewis, C; Ellison-Loschmann, L; Pearce, N; Blakely, T (2005) Ethnic inequalities in cancer survival in New Zealand: linkage study. American journal of public health,
More informationARTICLE. Methods of a national colorectal cancer cohort study: the PIPER Project
Methods of a national colorectal cancer cohort study: the PIPER Project Melissa J Firth, Katrina J Sharples, Victoria A Hinder, Jerome Macapagal, Diana Sarfati, Sarah L Derrett, Andrew G Hill, Charis Brown,
More informationBowel Cancer Quality Improvement Report
Bowel Cancer Quality Improvement Report 2019 Released 2019 health.govt.nz This report publishes quality performance indicator data from patients diagnosed with colorectal cancer in New Zealand between
More informationDownloaded from:
Sarfati, D; Tan, L; Blakely, T; Pearce, N (2011) Comorbidity among patients with colon cancer in New Zealand. The New Zealand medical journal, 124. p. 1338. ISSN 0028-8446 Downloaded from: http://researchonline.lshtm.ac.uk/57/
More informationHazardous drinking in 2011/12: Findings from the New Zealand Health Survey
Hazardous drinking in 11/12: Findings from the New Zealand Health Survey This report presents key findings about alcohol use and hazardous drinking among adults aged 15 years and over, which come from
More informationOncologist. The. Disparities in Cancer Care. Disparities in Cancer Care in Australia and the Pacific
The Oncologist Disparities in Cancer Care Disparities in Cancer Care in Australia and the Pacific IAN OLVER,FRANCA MARINE,PAUL GROGAN Cancer Council Australia, Sydney, New South Wales, Australia Key Words.
More informationUnequal Impact II: Māori and Non-Māori Cancer Statistics by Deprivation and Rural Urban Status
Unequal Impact II: and Non- Cancer Statistics by Deprivation and Urban Status 2002 2006 Te Rōpū Rangahau Hauora a Eru Pōmare University of Otago, Wellington Citation: Robson B, Purdie G, Cormack, D. 2010.
More informationSummary of the BreastScreen Aotearoa Mortality Evaluation
Summary of the BreastScreen Aotearoa Mortality Evaluation 1999 2011 Released 2015 nsu.govt.nz Citation: Ministry of Health. 2015. Summary of the BreastScreen Aotearoa Mortality Evaluation 1999 2011. Wellington:
More informationTesticular cancer in New Zealand: A mystery to be solved
Testicular cancer in New Zealand: A mystery to be solved Dr Jason Gurney Department of Public Health, Wellington School of Medicine and Health Sciences, University of Otago Our questions for today: Why
More informationBMC Cancer. Open Access. Abstract. BioMed Central
BMC Cancer BioMed Central Research article The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study Diana Sarfati* 1, Sarah Hill 1,2, Tony
More informationSHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson
Diabetologia (2009) 52:1474 1478 DOI 10.1007/s00125-009-1380-1 SHORT COMMUNICATION Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More informationSocial inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand to
DOI 10.1007/s10552-011-9804-x ORIGINAL PAPER Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981 1986 to 2001 2004 Tony Blakely Caroline Shaw
More informationOn-going and planned colorectal cancer clinical outcome analyses
On-going and planned colorectal cancer clinical outcome analyses Eva Morris Cancer Research UK Bobby Moore Career Development Fellow National Cancer Data Repository Numerous routine health data sources
More informationDownloaded from:
Brewer, N; Pearce, N; Day, P; Borman, B (2012) Travel time and distance to health care only partially account for the ethnic inequalities in cervical cancer stage at diagnosis and mortality in New Zealand.
More informationTools, Reports, and Resources
Tools, Reports, and Resources What the National Cancer Database (NCDB) does for CoC-Accredited Programs By using the NCDB, CoC-accredited programs can proactively improve delivery and quality of care for
More informationwell-targeted primary prevention of cardiovascular disease: an underused high-value intervention?
well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution
More informationAlcohol use in advanced age: Findings from LiLACS NZ
Alcohol use in advanced age: Findings from LiLACS NZ Te Puāwaitanga O Ngā Tapuwae Kia Ora Tonu This report presents key findings about alcohol use in advanced age including patterns of use and the relationship
More informationMaori Surviving Cancer. Equity focus for Cancer Control / Cancer Survival
Maori Surviving Cancer Equity focus for Cancer Control / Cancer Survival My background Clinical; curative and palliative care Public health; Maori Strategy Unit Waikato -Midland Network NSU - indicators
More informationKey causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:
Preventive care - Chronic Disease Management in primary care: a population perspective Rod Jackson University of Auckland New Zealand (22/11/8) Key causes of preventable deaths in New Zealand In a population
More informationCanada: Equitable Cancer Care Access and Outcomes? Historic Observational Evidence: Incidence Versus Survival, Canada Versus the United States
Canada: Equitable Cancer Care Access and Outcomes? Historic Observational Evidence: Incidence Versus Survival, Canada Versus the United States This work is funded by the: Canadian Institutes of Health
More informationBreast screening. achieving equity. Key concepts: keyword: breastscreening
www.bpac.org.nz keyword: breastscreening Breast screening achieving equity Key concepts: Māori and Pacific women have lower rates of breast screening and as a result have a higher mortality rate from breast
More informationIJC International Journal of Cancer
IJC International Journal of Cancer Changing socioeconomic inequalities in cancer incidence and mortality: Cohort study with 54 million person-years follow-up 1981 2011 Andrea M. Teng, June Atkinson, George
More information5.2 Main causes of death Brighton & Hove JSNA 2013
Why is this issue important? We need to know how many people are born and die each year and the main causes of their deaths in order to have well-functioning health s. 1 Key outcomes Mortality rate from
More informationCancer Prevention: the gap between what we know and what we do
Cancer Prevention: the gap between what we know and what we do John D Potter MBBS PhD Public Health Sciences Division Fred Hutchinson Cancer Research Center Global Trends Global Trends Increasing population
More informationMeasuring cancer survival in populations: relative survival vs cancer-specific survival
Int. J. Epidemiol. Advance Access published February 8, 2010 Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2010; all rights reserved. International
More informationNational Cancer Programme. Work Plan 2015/16
National Cancer Programme Work Plan 2015/16 Citation: Ministry of Health. 2015. National Cancer Programme: Work plan 2015/16. Wellington: Ministry of Health. Published in October 2015 by the Ministry of
More informationSanjeewa Seneviratne 1,2,5*, Ian Campbell 1, Nina Scott 3, Rachel Shirley 4 and Ross Lawrenson 1
Seneviratne et al. BMC Public Health (2015) 15:46 DOI 10.1186/s12889-015-1383-4 RESEARCH ARTICLE Open Access Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage
More informationSurvival of Indigenous and non-indigenous Queenslanders after a diagnosis of lung cancer: a matched cohort study
Survival of and non- Queenslanders after a diagnosis of lung cancer: a matched cohort study Michael D Coory, Adele C Green, Janelle Stirling and Patricia C Valery Lung cancer is the commonest cancer among
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Sociodemographic characteristics of New Zealand adult smokers, ex-smokers, and non-smokers: results from the 2006 Census Sharon
More informationProfessor Jennie Connor. Department of Preventive and Social Medicine University of Otago, Dunedin
Professor Jennie Connor Department of Preventive and Social Medicine University of Otago, Dunedin New Zealand Population Health Congress 2014 acute and chronic effects benefits and harms pattern and volume
More informationGhosts in the Machine: Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand
Ghosts in the Machine: Patient Journeys Through Cancer Treatment Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand Age-Standardised Cancer Incidence (100,000 population)
More informationNCIN Conference Feedback 2015
NCIN Conference Feedback 2015 Parallel Sessions Treatments (Black type is the topic; blue type are comments) The use of population and research data in the development of guidelines for cancer treatment
More informationMidland Region All Boards Development Days. Midland Cancer Network. 15, 16 October, 2015
Midland Region All Boards Development Days Midland Cancer Network 15, 16 October, 2015 NZ cancer incidence 1948-2011 Source: NZ Cancer 0.0 50.0 100.0 150.0 200.0 250.0 300.0 350.0 400.0 0 5000 10000 15000
More informationRe-audit of Radiotherapy Waiting Times 2005
Abstract Re-audit of Radiotherapy Waiting Times 2005 E. Summers, M Williams Royal College of Radiologists, 38 Portland Place, London W1B 4JQ, UK Aim: To determine current waiting times for radiotherapy
More informationCancer in the South Island of New Zealand Health Needs Assessment
Cancer in the South Island of New Zealand Health Needs Assessment - 21 Southern Cancer Network July 21 Prepared by: Tony Macdonald, Claire Worsfold, Robert Weir Disclaimer Information within the report
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 117 No 1190 ISSN 1175 8716 Smoking in a New Zealand university student sample Kypros Kypri and Joanne Baxter Abstract Aims The aims of this study were to estimate the
More informationSurvival comorbidity. Mrs Retha Steenkamp Senior Statistician UK Renal Registry. UK Renal Registry 2011 Annual Audit Meeting
Survival comorbidity Mrs Retha Steenkamp Senior Statistician UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting Importance of co-morbidities in survival Co-morbidities collected by the Renal
More informationInvestigation of relative survival from colorectal cancer between NHS organisations
School Cancer of Epidemiology something Group FACULTY OF OTHER MEDICINE AND HEALTH Investigation of relative survival from colorectal cancer between NHS organisations Katie Harris k.harris@leeds.ac.uk
More informationWhat s new in cardiovascular disease risk assessment and management for primary care clinicians
Cardiovascular system What s new in cardiovascular disease risk assessment and management for primary care clinicians The recently released 2018 Cardiovascular Disease Risk Assessment and Management for
More informationInfectious Disease Surveillance in NZ. Michael Baker Department of Public Health, University of Otago, Wellington
Infectious Disease Surveillance in NZ Michael Baker Department of Public Health, University of Otago, Wellington michael.baker@otago.ac.nz Outline Current best practice High quality surveillance of specific
More informationPharmaco-epidemiological outcome research
Pharmaco-epidemiological outcome research Using the PHARMO-Eindhoven Cancer Registry linkage Lonneke van de Poll-Franse Professor of Cancer Epidemiology and Survivorship, Tilburg University & Head department
More informationEnd of Life Care in Nova Scotia: Surveillance Report. Dr. Fred Burge June 13, 2008
End of Life Care in Nova Scotia: Surveillance Report Dr. Fred Burge June 13, 2008 What is the Network for End of Life Studies (NELS)? Research group based at Dalhousie University, Capital Health, Cancer
More informationUsing claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center
Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association If nobody smoked tobacco in New Zealand from 2020 onwards, what effect would this have on ethnic inequalities in life expectancy?
More informationDr Chris Jackson. Consultant Medical Oncologist Southern Blood and Cancer Service (SDHB) University of Otago
Dr Chris Jackson Consultant Medical Oncologist Southern Blood and Cancer Service (SDHB) University of Otago 14:50-15:15 Priorities for Cancer Care in NZ - The Cancer Society's View Priorities for Cancer
More informationSocioeconomic Inequalities in Cancer Survival in New Zealand: The Role of Extent of Disease at Diagnosis
915 Socioeconomic Inequalities in Cancer Survival in New Zealand: The Role of Extent of Disease at Diagnosis Mona Jeffreys, 1,2 Diana Sarfati, 3 Vladimir Stevanovic, 4 Martin Tobias, 5 Chris Lewis, 4 Neil
More informationIschaemic cardiovascular disease
Ischaemic cardiovascular disease What are the PHO performance programme indicators and how are they best achieved? 40 BPJ Issue 36 Supporting the PHO Performance Programme The PHO Performance Programme
More informationChapter 6: Combined Cardiovascular Risk Factors
Chapter 6: Combined Cardiovascular Risk Factors Key points Cardiovascular diseases such as coronary heart disease and stroke cause 44% of all deaths in New Zealand. The 1996/97 Health Survey provides information
More informationNATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit
NATIONAL BOWEL CANCER AUDIT The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit NBOCA: Feasibility Study Date of publication: Thursday 9 th August
More informationAsthma Clinics for Children in General Practice
Asthma Clinics for Children in General Practice Outline: Why start an asthma clinic? The Equity Issue What to do? What did we roll out? What happened? What worked and what did not? Manurewa s Population
More informationJAMA, January 11, 2012 Vol 307, No. 2
JAMA, January 11, 2012 Vol 307, No. 2 Dementia is associated with increased rates and often poorer outcomes of hospitalization Worsening cognitive status Adequate chronic disease management is more difficult
More informationThe impact of respiratory disease in New Zealand: 2018 update
The impact of respiratory disease in New Zealand: 2018 update Dr Lucy Telfar Barnard Jane Zhang This report was prepared for the Asthma and Respiratory Foundation NZ Contents 1. List of Figures... 5 2.
More informationCohort and Case Control Analyses of Breast Cancer Mortality: BreastScreen Aotearoa
Cohort and Case Control Analyses of Breast Cancer Mortality: BreastScreen Aotearoa 1999-2011 by Stephen Morrell, 1 Richard Taylor, 1 David Roder, 2 Bridget Robson 3 1. School of Public Health and Community
More informationTobacco Trends 2008 A brief update of tobacco use in New Zealand
Tobacco Trends 2008 A brief update of tobacco use in New Zealand Please note: Care must be taken when comparing smoking rates as rates may vary depending on the survey type, age range of respondents, definition
More informationWHAT FACTORS INFLUENCE AN ANALYSIS OF HOSPITALIZATIONS AMONG DYING CANCER PATIENTS? AGGRESSIVE END-OF-LIFE CANCER CARE. Deesha Patel May 11, 2011
WHAT FACTORS INFLUENCE HOSPITALIZATIONS AMONG DYING CANCER PATIENTS? AN ANALYSIS OF AGGRESSIVE END-OF-LIFE CANCER CARE. Deesha Patel May 11, 2011 WHAT IS AGGRESSIVE EOL CARE? Use of ineffective medical
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association The Voice of Experience: Results from Cancer Control New Zealand s first national cancer care survey Inga O Brien, Emma Britton,
More informationDr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)
Professor Gerry Devlin Clinical Cardiologist and Interventional Cardiologist NZ Heart Foundation Hamilton Dr Joan Leighton General Practitioner Heart Foundation Christchurch 14:00-14:55 WS #106: Whats
More informationPSA testing in New Zealand general practice
PSA testing in New Zealand general practice Ross Lawrenson, Charis Brown, Fraser Hodgson. On behalf of the Midland Prostate Cancer Study Group Academic Steering Goup: Zuzana Obertova, Helen Conaglen, John
More informationMāori Health Profile 2015
WHANGANUI DISTRICT HEALTH BOARD TE POARI HAUORA O WHANGANUI Māori Health Profile 2015 Te taupori Population In 2013, 15,850 Māori lived in the Whanganui District Health Board (DHB) region, 25% of the District
More informationAssessing Toxicity Risk in Senior Chemotherapy Patients (AT RISC) a pilot prospective audit
Assessing Toxicity Risk in Senior Chemotherapy Patients (AT RISC) a pilot prospective audit Dr Laird Cameron MBChB BSc, Dr Annie Wong MBChB, Dr C Barrow MBChB, Dr K Clarke MBChB, Dr B Luey MBChB, Dr A
More informationChapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter Cancer 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Incidence of Cancer on Renal Replacement Therapy Figures.1-.6 and table.1 show the cumulative incidence of non-skin cancer in patients
More informationMāori Health Profile 2015
BAY OF PLENTY DISTRICT HEALTH BOARD TE HAUORA A TOI Māori Health Profile 2015 Te taupori Population In 2013, 53,700 Māori lived in the Bay of Plenty District Health Board region, 25% of the District s
More informationTatau Kahukura. Mäori Health Chart Book. Public Health Intelligence Monitoring Report No.5
Tatau Kahukura Mäori Health Chart Book 2006 Public Health Intelligence Monitoring Report No.5 The title of this publication, Tatau Kahukura, refers to valuable, high-quality information that has been woven
More informationNight Shift Work and Occupational Exposures
Night Shift Work and Occupational Exposures Sarah M Jay, PhD Sleep/Wake Research Centre Massey University, Wellington Shift Work in New Zealand Defined as any work that displaces sleep (may or may not
More informationCorrelations of Obesity, Comorbidity and Treatment: Implications for Survival Analysis and Interpretation
Correlations of Obesity, Comorbidity and Treatment: Implications for Survival Analysis and Interpretation Rachel Ballard-Barbash, MD, MPH Applied Research Program (ARP) Division of Cancer Control and Population
More informationLucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*
Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in
More informationEthnic disparities in breast cancer survival in New Zealand: which factors contribute?
Tin Tin et al. BMC Cancer (2018) 18:58 DOI 10.1186/s12885-017-3797-0 RESEARCH ARTICLE Open Access Ethnic disparities in breast cancer survival in New Zealand: which factors contribute? Sandar Tin Tin 1*,
More informationChapter 4: High Blood Pressure
Key points Chapter 4: High blood pressure is common in New Zealand and is an important contributing factor to heart disease and stroke. Actual blood pressure measurements were not carried out as part of
More informationSurvival of End Stage Renal Failure Patients with Cancer
Survival of End Stage Renal Failure Patients with Cancer Angela Webster Centre for Kidney Research, The Children s Hospital at Westmead Department of Renal Medicine, Westmead Hospital, NSW School of Public
More informationColorectal cancer care in Victoria ( )
Colorectal cancer care in Victoria (2011-2015) Mr Brian Hodgkins Please note: Some changes have been made for the purpose of publication Colorectal Cancer Summit working party Chairs: Geoff Chong Brian
More informationNational Cancer Programme. Work Plan 2014/15
National Cancer Programme Work Plan 2014/15 Citation: Ministry of Health. 2014. National Cancer Programme: Work Plan 2014/15. Wellington: Ministry of Health. Published in December 2014 by the Ministry
More informationCancer Outcomes and Services Dataset: Implications for clinical teams
Cancer Outcomes and Services Dataset: Implications for clinical teams Mick Peake Clinical Lead, NCIN National Clinical Lead, NHS Cancer Improvement Consultant & Senior Lecturer in Respiratory Medicine,
More informationSuicide Facts. Deaths and intentional self-harm hospitalisations
Suicide Facts Deaths and intentional self-harm hospitalisations 2012 Citation: Ministry of Health. 2015. Suicide Facts: Deaths and intentional self-harm hospitalisations 2012. Wellington: Ministry of Health.
More informationPresentation map. Report - Township - Prestwich. PHE - Crown copyright and database rights 2014, Ordnance Survey ONS Crown Copyright 2014
Presentation map PHE - Crown copyright and database rights 14, Ordnance Survey 16969 ONS Crown Copyright 14 1/16 Population Population by age group, 12 Population by age group, 12 aged under 16 (22.2 %)
More informationUnknown Primary Service for patients at Chesterfield Royal Hospital
Unknown Primary Service for patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Louise Merriman GP Cancer Lead With thanks to Macmillan Cancer Support, who
More informationCHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand
CHAPTER 9 End Stage Kidney Disease in Aotearoa/New Zealand ANZDATA gratefully acknowledges the patients and their families and the clinicians who provided data, and the contributions of the Aotearoa/New
More informationThe Vision. The Objectives
The Vision Older people participate to their fullest ability in decisions about their health and wellbeing and in family, whānau and community life. They are supported in this by co-ordinated and responsive
More informationReport - Ward: Blythe; Solihull (Ward (2013)) Presentation map
Presentation map PHE - Crown copyright and database rights 214, Ordnance Survey 16969 ONS Crown Copyright 214 1/17 Population Population by age group, 212 Population by age group, 212 aged under 16 (19.1
More informationNew Zealand Palliative Care: A Working Definition.
New Zealand Palliative Care: A Working Definition. 1. Preamble The NZ Palliative Care Strategy (2001) aims to set in place a systematic and informed approach to the provision and funding of palliative
More informationHealth Needs Assessment
Health Needs Assessment District Health Board For the Ministry of Health Contact Person: Associate Professor Barry Borman Centre for Public Health Research Massey University, Wellington Campus PO Box 76,
More informationAdmissions to acute psychiatric inpatient services in Auckland, New Zealand: A demographic and diagnostic review
Admissions to acute psychiatric inpatient services in Auckland, New Zealand: A demographic and diagnostic review Author Wheeler, Amanda, Robinson, Elizabeth, Robinson, Gail Published 2005 Journal Title
More informationMāori Health Profile 2015
HUTT VALLEY DISTRICT HEALTH BOARD TE POARI HAUORA O TE AWAKAIRANGI Māori Health Profile 2015 Te taupori Population In 2013, 23,800 Māori lived in the Hutt District Health Board region, 17% of the District
More information